Suppr超能文献

转移相关结肠癌-1是宫颈癌的一种新型预后标志物。

Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer.

作者信息

Guo Lan, Lu Wanggui, Zhang Xuan, Luo Dixian, Zhang Hongwen

机构信息

Department of Gynaecology and Obstetrics, The First People's Hospital of Chenzhou City Chenzhou, HN 423000, China.

Department of Gynaecology and Obstetrics, The Second Xiangya Hospital Central South University Changsha, HN 410011, China.

出版信息

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4150-5. eCollection 2014.

Abstract

AIMS

To investigate metastasis associated in colon cancer 1 (MACC1) expression in cervical cancer.

METHODS

One hundred and four paraffin-embedded cervical cancer specimens were immunohistochemically analyzed for MACC1 expression. The expression of MACC1 in 8 pairs of cervical cancer and adjacent normal cervical tissues were detected by Real-time PCR.

RESULTS

MACC1 expression was upregulated in cervical cancer tissues compared with adjacent normal cervical tissues. Patients with higher MACC1 expression had shorter overall survival time, whereas those with lower ASAP1 expression survived longer (P = 0.029). Moreover, high expression of MACC1 was correlated with FIGO stage (P = 0.039) and lymph nodes metastasis (P = 0.003) of this disease. Multivariate analysis revealed that MACC1 was an independent prognostic factor (P = 0.043) for the overall survival of cervical cancer patients.

CONCLUSION

Our study suggests that MACC1 may contribute to tumor development and progression in cervical cancer, and that MACC1 could be a useful marker for the prognosis of cervical cancer.

摘要

目的

研究结肠癌转移相关蛋白1(MACC1)在宫颈癌中的表达情况。

方法

采用免疫组织化学方法分析104例石蜡包埋的宫颈癌标本中MACC1的表达。应用实时荧光定量PCR检测8对宫颈癌组织及癌旁正常宫颈组织中MACC1的表达。

结果

与癌旁正常宫颈组织相比,宫颈癌组织中MACC1表达上调。MACC1高表达患者的总生存时间较短,而ASAP1低表达患者生存时间较长(P = 0.029)。此外,MACC1高表达与该疾病的国际妇产科联盟(FIGO)分期(P = 0.039)及淋巴结转移(P = 0.003)相关。多因素分析显示,MACC1是宫颈癌患者总生存的独立预后因素(P = 0.043)。

结论

我们的研究表明,MACC1可能促进宫颈癌的肿瘤发生和进展,并且MACC1可能是宫颈癌预后的一个有用标志物。

相似文献

1
Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer.
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4150-5. eCollection 2014.
7
Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer.
Pathol Oncol Res. 2013 Oct;19(4):749-53. doi: 10.1007/s12253-013-9638-9. Epub 2013 Jun 5.
9
High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma.
Int J Clin Exp Pathol. 2014 Feb 15;7(3):1060-8. eCollection 2014.
10
MACC1 expression is an indicator of recurrence in early-stage glottic cancer.
Jpn J Clin Oncol. 2020 Apr 7;50(4):392-398. doi: 10.1093/jjco/hyz206.

引用本文的文献

1
Five Cellular Genes as Candidates for Cervical Adenocarcinoma Molecular Markers.
Cancers (Basel). 2025 May 3;17(9):1558. doi: 10.3390/cancers17091558.
3
Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.
Mol Cell Biochem. 2021 Dec;476(12):4363-4385. doi: 10.1007/s11010-021-04249-4. Epub 2021 Aug 28.
5
MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion.
Exp Ther Med. 2019 Nov;18(5):3650-3658. doi: 10.3892/etm.2019.7989. Epub 2019 Sep 9.
6
Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients.
Front Oncol. 2019 Feb 5;9:28. doi: 10.3389/fonc.2019.00028. eCollection 2019.
7
Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer.
Contemp Oncol (Pozn). 2018;22(1):1-7. doi: 10.5114/wo.2018.74386. Epub 2018 Apr 3.
8
Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer.
Oncol Lett. 2017 Oct;14(4):3899-3908. doi: 10.3892/ol.2017.6670. Epub 2017 Jul 26.

本文引用的文献

1
MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance.
Oncol Lett. 2012 Oct;4(4):783-791. doi: 10.3892/ol.2012.784. Epub 2012 Jul 2.
2
New technologies and procedures for cervical cancer screening.
Vaccine. 2012 Nov 20;30 Suppl 5:F107-16. doi: 10.1016/j.vaccine.2012.05.088.
3
Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.
Ann Surg. 2012 Nov;256(5):763-71; discussion 771. doi: 10.1097/SLA.0b013e318272de87.
4
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2012 Oct;23 Suppl 7:vii27-32. doi: 10.1093/annonc/mds268.
7
Cancer burden in Africa and opportunities for prevention.
Cancer. 2012 Sep 15;118(18):4372-84. doi: 10.1002/cncr.27410. Epub 2012 Jan 17.
8
Cervical cancer prevention: better tests, better tools, and more equitable outcomes.
J Natl Cancer Inst. 2011 Sep 21;103(18):1352-3. doi: 10.1093/jnci/djr330. Epub 2011 Sep 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验